Jennifer Adair, PhD


The focus of my research for the past 8 years has been in translating blood stem cell gene therapy for a variety of diseases into clinically viable treatment approaches. My laboratory is on the frontlines of bringing these new therapies to patients, and in doing so has experienced firsthand the hurdles in feasibility, efficiency and safety that warrant further innovation in the field. This unique perspective has driven us to bring together diverse technologies, some well outside my scientific comfort zone, to overcome these issues.

As a result, I am an inventor on several patents, have a diverse research funding portfolio and have experience interacting with industry as a consultant, sponsored research recipient and licensing partner. I have been a member of ASGCT since 2010, served on the New Investigator Committee as a member (2011-2014) and chair (2014-2016), as well as on the Hematologic and Immunologic Diseases Committee (2016-present).

Board & Officers

The ASGCT Board of Directors and the Society's officers have full responsibility for the management, direction and control of the Society.

2019
22nd Annual Meeting
April 29 – May 2 | Washington D.C.
Close